MARKET RADAR
SENSEX     NIFTY      Refresh
Moneycontrol.com India | Notes to Account > Miscellaneous > Notes to Account from Titan Bio-Tech - BSE: 524717, NSE: N.A
YOU ARE HERE > MONEYCONTROL > MARKETS > MISCELLANEOUS > NOTES TO ACCOUNTS - Titan Bio-Tech
Titan Bio-Tech
BSE: 524717|ISIN: INE150C01011|SECTOR: Miscellaneous
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 20, 11:15
12.55
0
VOLUME 100
Titan Bio-Tech is not listed on NSE
« Mar 10
Notes to Accounts Year End : Mar '11
1 Inventories: Cost of Closing Stock of Finished Goods is lower of
 realizable value or cost as certified by the management. However cost
 of each & every item, if not calculated as per AS-2, could not be ruled
 out as the company deals in more than 500 items and labour cost /
 factory overheads differs for each batch produced.
 
 2 Financial and Derivative Instruments:
 
 No amount of Derivative contracts by the company is outstanding as on
 31st March 2011.
 
 3 Contingent Liabilities: In the opinion of the Board of Directors, the
 company has not any material claims where liability may arise in future
 except ESI Demand of Rs.101365/ - and Excise Duty of Rs.123273/- paid
 under protest.
 
 4 a) In the opinion of the Board of Directors ,the aggregate value of
 Current Assets,
 
 Loans & Advances on realization in ordinary course of business will not
 be less than the amount at which they are stated in the Balance Sheet.
 However the amounts deposited against pending Disputes (Stay Amount)
 are shown under the head  Loans & Advances and have not been
 acknowledged as liabilities for Rs.11,18,318.19.
 
 b) Balance of Sundry Debtors, Unsecured Loans and Sundry Creditors are
 Subject to Confirmation.
 
 5 Segment Reporting (AS-17):- The Company''s operation mainly comprises
 of manufacturing of Peptone, Extract, Culture Media and trading of
 Handicap Goods.  The Company is doing business from three places i.e.
 Bhiwadi, Delhi & Kolkatta. The Key Figures related to sales / purchases
 inclusive of Branch Transfer are given below.  However, the Company is
 operating through common Bank Accounts at Delhi for all the business
 places.
 
 6 As per Accounting Standard (AS-18) on related party disclosures
 issued by the Institute of Chartered Accountants of India, the
 disclosure of Transactions with the related party as defined in the
 Accounting Standard are given below:
 
 I. Names of Related Parties with whom transactions were carried out
 during the year and Description of relationship:
 
 Name of the Related Party Nature of Relationship
 
 Titan Securities Limited A company in which three Directors are common.
 
 Titan Media Limited A company in which two Directors are common.
 
 7 Previous year figures have been re-worked, re-arranged, re-grouped
 and re-classified wherever necessary.
 
 8 Prior period expenditure of Rs.255310/- on account of excise duty
 MOT Charges and Interest has been debited to the Profit and Loss a/c.
 
 9 Schedules from A to J form an integral part of the accounts for the
 year ended 31st March, 2011.
 
 10 The Ministry of Company Affairs Government of India vides its Order
 No. 46/15/2006- CL-III dated 27th April 2006 issued under Section 211
 (4) of the Companies Act, 1956 has exempted the Company from disclosure
 of quantitative Details in the Profit and Loss Account under Para 3(1)
 (a) enclosing the quantitative and amount wise details of its turnover
 by reference to each class of goods manufactured & traded ) 3(ii) (1)
 (item-wise quantities and value to raw material consumed) and 3(ii)
 (a)(2) (quantitative and value analysis of opening and closing stock of
 goods produced by reference to the each class of goods) of part II of
 Schedule VI to the Companies Act, 1956 and consequently, no such
 details has been furnished.
Source : Dion Global Solutions Limited
Quick Links for titanbiotech
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.